Beacon Transcript

Information which Matters to You

Tuesday, April 13, 2021
Log in
  • National News
  • National News
  • Business
  • Business
  • Technology
  • Technology
  • Health
  • Health
  • Science
  • Science
  • About Us
    • Contact Us
    • Authors & Contributors
    • Privacy Policy GDPR
  • About Us
    • Contact Us
    • Authors & Contributors
    • Privacy Policy GDPR

Recent Articles

Ancient Babylonian Clay Tablet Holds the First Trigonometric Table

Ancient Babylonian Clay Tablet Holds the First Trigonometric Table

August 26, 2017 By Clayton Meason

The CDC Draws Attention To The Spike In Cyclosporiasis Cases

The CDC Draws Attention To The Spike In Cyclosporiasis Cases

August 11, 2017 By Troy G. Bennett

Travis Kalanick Resigns from His Position as Uber’s CEO

Travis Kalanick Resigns from His Position as Uber’s CEO

June 22, 2017 By Troy G. Bennett

Amazon Refunds Parents Whose Children Made Purchases Without Permission

Amazon Refunds Parents Whose Children Made Purchases Without Permission

June 2, 2017 By Clayton Meason

McDonald’s Has Been Quietly Altering Its Vanilla Ice Cream Recipe

McDonald’s Has Been Quietly Altering Its Vanilla Ice Cream Recipe

May 21, 2017 By Jennifer Licata

Washington Post Will Be Expanding Its Newsroom

Washington Post Will Be Expanding Its Newsroom

December 28, 2016 By Troy G. Bennett

Johnson & Johnson Received A $1 Billion Verdict

December 2, 2016 By Troy G. Bennett

Email, RSS Follow
J&J bulding faces billion settlement

Johnson & Johnson were sentenced to a $1 billion verdict by a Texas jury.

Beacon Transcript – Johnson & Johnson were sentenced to a $1 billion verdict by a Texas jury as their hip implants were found to be faulty and host unrevealed problems.

Johnson & Johnson is a New Brunswick, New Jersey-based multinational company which specializes in medical and pharmaceutical devices. The company is also a packaged goods for consumers manufacturer.

Earlier this week, Johnson & Johnson or J&J received the verdict in the case involving one of the company’s hip replacement products.

The current $1 billion fine verdict is not the first and may not be the last such case the company has to face involving the same product.

The unit in question is one of the DePuy hip replacement products, the ULTAMET Metal-on-Metal. DePuy is a J&J subsidiary which tests and produces medical devices aimed at solving orthopaedical, neuroscience, and spinal care aids and solutions.

ULTAMET Metal-on-Metal is one such product as it acts as a hip replacement for patients in need. However, the product has been causing quite some controversies due mostly to the material on which it is based.

A number of lawsuits have already been filed against J&J. Patients have started complaining that the prosthetics may be the cause of or lead to bloodstream poisonings.

Besides being dangerous in itself, this usually also requires a change of prosthetics as the current devices were observed to fall off, which in turn requires their removal.

The cause of the bloodstream poisoning is thought to be determined by cobalt and chromium materials leaks coming from the metal-on-metal implants.

As the current $1 billion verdict case was not the first case of its type, it nonetheless features the highest verdict.

J&J was involved in its first ULTAMET Metal-on-Metal lawsuit back in 2014, case won by the company.

Since then, Johnson & Johnson was faced with a number of other similar trials, all featuring similar or the same claims.

Both the first and the subsequent cases claimed that the company did, in fact, know about the potential blood poisoning issue.

However, despite the potential dangers caused by the metal-on-metal device, the company decided to go ahead and ignore them. It also reportedly failed to denounce the issues and also continued selling the devices.

Just earlier this year, a Dallas-based jury decided in favor of a number of 5 patients that filed a lawsuit with these claims.

As the initial settlement value was of $502 million, a jury later decided to reduce the sum to $150 million.

According to company statements, J&J is planning on also appealing on the current $1 billion verdict case. The verdict, which was also delivered by a Dallas-based jury set a $1 billion verdict for the lawsuit’s punitive damages.

The six patients to have filed the case have been granted over $30 million so as to account for the damages caused by the reportedly faulty device.

As J&J is considering an appeal, the company together with DePuy have asked judges for a temporal pause in their other hip device trials.

The company will reportedly have to face a number of other 8,900 lawsuits concerning the hip replacement product.

Later Edit: As the initial article was talking about a settlement, the court has now ruled a verdict. The company’s take on the matter has also been included as Johnson & Johnson have, in the meantime, issued a public statement.

According to Mindy Tinsley, a DePuy spokesperson, the company has been and is constantly trying to offer new and innovative medical solutions. These are designed and produced so as to offer its users the chance of living an active and comfortable life.

As all of the company’s designs undergo rigurous tests and follow the regulations, the company does not consider to be responsible of the unexpected adverse reactions.

Tinsley stated that the ULTAMET Metal-on-Metal product, besides rigurously following the regulations and having had its design and utility tested, it is also backed by clinical data.

As the strong track record of clinical data went to show, the metal prosthetic was demonstrated to have restored mobility and reduced the users’ pain.

As opposed to other similar cases, J&J and DePuy drew attention to the case restrictions and rulings. The companies have had to defend themselves against six simultaneos plaintiffs.

This means that they have had to move for mistral six times and may have not been given the chance of fairly and properly defending themselves against the allegations.

As such, the companies will be preparing post-trial motions so as to challenge the $1 billion verdict as they have strong motives to do so. They will also be continuing their long-term defense in other similar allegations trials.

Image Source: Wikimedia

Email, RSS Follow

Filed Under: Business

Recent Posts

  • Security Guard List As Suspect in 1974 Stanford University Chapel Slaying Kills Himself June 29, 2018
  • Texas Teens Arrested After Decomposing Body of Elderly Woman Found in Garage June 28, 2018
  • Montana Woman in Custody After Forcing Ex to Have Sex with Her June 27, 2018
  • Newly Released Audio Transcript Proves Monalisa Perez Objected to Deadly YouTube Prank June 26, 2018
  • Virginia Woman Shoots New Zealand Man Who Smashed Glass Door with Brick   June 26, 2018
  • Arizona Woman Lied About Kidnapping to Cover Boyfriend’s Slaying June 25, 2018
  • Brooklyn Man Arrested in Niagara Falls Allegedly Chopped off Pregnant Wife’s Arms with Steak Knife June 25, 2018

Related Articles

  • Ancient Babylonian Clay Tablet Holds the First Trigonometric Table

    Aug 26, 2017
  • map of cyclosporiasis cases in 2013

    The CDC Draws Attention To The Spike In Cyclosporiasis Cases

    Aug 11, 2017
  • Travis Kalanick

    Travis Kalanick Resigns from His Position as Uber’s CEO

    Jun 22, 2017
  • Amazon box

    Amazon Refunds Parents Whose Children Made Purchases Without Permission

    Jun 2, 2017
  • ice cream

    McDonald’s Has Been Quietly Altering Its Vanilla Ice Cream Recipe

    May 21, 2017
  • washington post

    Washington Post Will Be Expanding Its Newsroom

    Dec 28, 2016
  • disney store six new retailers

    Six New Retailers Will Give Up On-Call Scheduling

    Dec 21, 2016
  • sumner redstone viacom studios

    Sumner Redstone Will Officially Step Down From Viacom

    Dec 17, 2016
  • ibm new employees

    IBM Expressed Its Intention Of Hiring New Employees

    Dec 15, 2016
  • capsugel capsules

    Lonza Is Reportedly In Talks With Capsugel

    Dec 12, 2016

Categories

  • Business
  • Entertainment
  • Health
  • National News
  • Nature
  • Science
  • Stocks
  • Technology
  • US
  • World

Copyright © 2021 beacontranscript.com

About · Privacy Policy · Terms of Use · Contact